Butyrate-induced differentiation of Caco-2 cells is mediated by vitamin D receptor

被引:46
作者
Gaschott, T
Werz, O
Steinmeyer, A
Steinhilber, D
Stein, J
机构
[1] Univ Frankfurt, Dept Internal Med 2, Div Gastroenterol & Clin Nutr, D-60590 Frankfurt, Germany
[2] Univ Frankfurt, Inst Pharmaceut Chem, D-60590 Frankfurt, Germany
[3] Schering AG, Corp Res, D-1000 Berlin, Germany
关键词
butyrate; Caco-2; cells; differentiation; p21(Waf1/Cip1); vitamin D receptor; vitamin D receptor antagonist;
D O I
10.1006/bbrc.2001.5832
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Butyrate in combination with 1,25-dihydroxyvitamin D-3 [1,25-(OH)(2)D-3] produces a synergistic effect on cell differentiation of human colon cancer cells (Caco-2). The objective of this study was to confirm the role of the vitamin D receptor (VDR) in butyrate-induced cell differentiation of Caco-2. We studied the effects of the novel VDR antagonist ZK 191732 on butyrate-induced cell differentiation and on p21(Waf1/Cip1) expression. Butyrate induced cell differentiation which was further enhanced after addition of 1,25-(OH)2D3. Experiments using ZK 191732 indicate that the synergistic effect of butyrate and 1,25-(OH)2D3 was due to butyrate-induced upregulation of VDR. While butyrate alone increased expression of p21(Waf1/Cip1) and combined exposure of butyrate and 1,25-(OH)2D3 resulted in a synergistic amplification, p21(Waf1/Cip1) expression did not change from the control level after treatment with butyrate plus ZK 191732. These data further imply that butyrate-induced differentiation and p21(Waf1/Cip1) expression of Caco-2 cells occur via upregulation of VDR. (C) 2001 Academic Press.
引用
收藏
页码:690 / 696
页数:7
相关论文
共 34 条
[1]   p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells [J].
Archer, SY ;
Meng, SF ;
Shei, A ;
Hodin, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6791-6796
[2]   1,25-DIHYDROXYVITAMIN-D3 AND HUMAN BONE-DERIVED CELLS-INVITRO - EFFECTS ON ALKALINE-PHOSPHATASE, TYPE-I COLLAGEN AND PROLIFERATION [J].
BERESFORD, JN ;
GALLAGHER, JA ;
RUSSELL, RGG .
ENDOCRINOLOGY, 1986, 119 (04) :1776-1785
[3]   SEQUENTIAL INDUCTION OF 5-LIPOXYGENASE GENE-EXPRESSION AND ACTIVITY IN MONO-MAC-6 CELLS BY TRANSFORMING GROWTH-FACTOR-BETA AND 1,25-DIHYDROXYVITAMIN-D3 [J].
BRUNGS, M ;
RADMARK, O ;
SAMUELSSON, B ;
STEINHILBER, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (01) :107-111
[4]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[5]   Structure activity relationship of carboxylic ester antagonists of the vitamin D3 receptor [J].
Bury, Y ;
Steinmeyer, A ;
Carlberg, C .
MOLECULAR PHARMACOLOGY, 2000, 58 (05) :1067-1074
[6]   HYPOMETHYLATION OF DNA DURING DIFFERENTIATION OF FRIEND-ERYTHROLEUKEMIA CELLS [J].
CHRISTMAN, JK ;
WEICH, N ;
SCHOENBRUN, B ;
SCHNEIDERMAN, N ;
ACS, G .
JOURNAL OF CELL BIOLOGY, 1980, 86 (02) :366-370
[7]  
EISMAN JA, 1987, CANCER RES, V47, P21
[8]   Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells [J].
Gaschott, T ;
Steinhilber, D ;
Milovic, V ;
Stein, J .
JOURNAL OF NUTRITION, 2001, 131 (06) :1839-1843
[9]   1,25-Dihydroxycholecalciferol enhances butyrate-induced p21Waf1/Cip1 expression [J].
Gaschott, T ;
Wächtershäuser, A ;
Steinhilber, D ;
Stein, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (01) :80-85
[10]  
GIULIANO AR, 1991, ARCH BIOCHEM BIOPHYS, V2, P261